NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,316,678 | -91.8% | 81,528 | -79.0% | 0.00% | -90.0% |
| Q2 2023 | $16,115,239 | -4.8% | 388,319 | +37.9% | 0.02% | -9.1% |
| Q1 2023 | $16,933,076 | -27.9% | 281,561 | -12.1% | 0.02% | -33.3% |
| Q4 2022 | $23,496,571 | +4.9% | 320,335 | +8.7% | 0.03% | +3.1% |
| Q3 2022 | $22,395,789 | +27.1% | 294,759 | +16.2% | 0.03% | -27.3% |
| Q2 2022 | $17,624,000 | -20.1% | 253,584 | -4.8% | 0.04% | -4.3% |
| Q1 2022 | $22,065,000 | +7.5% | 266,332 | -2.6% | 0.05% | +17.9% |
| Q4 2021 | $20,527,000 | -60.0% | 273,404 | -38.1% | 0.04% | -62.1% |
| Q3 2021 | $51,282,000 | -24.4% | 441,437 | +44.3% | 0.10% | -21.4% |
| Q2 2021 | $67,841,000 | +0.6% | 305,841 | -40.0% | 0.13% | -3.7% |
| Q1 2021 | $67,432,000 | +1.0% | 510,156 | +32.2% | 0.14% | +0.7% |
| Q4 2020 | $66,753,000 | +10.5% | 385,765 | -28.9% | 0.14% | +0.7% |
| Q3 2020 | $60,420,000 | +29.9% | 542,812 | -30.8% | 0.13% | +24.1% |
| Q2 2020 | $46,527,000 | +290.4% | 784,600 | +343.3% | 0.11% | +237.5% |
| Q1 2020 | $11,919,000 | -54.3% | 176,995 | -42.8% | 0.03% | -40.7% |
| Q4 2019 | $26,068,000 | -4.6% | 309,337 | -15.4% | 0.05% | -10.0% |
| Q3 2019 | $27,335,000 | +1193.0% | 365,537 | +993.6% | 0.06% | +1100.0% |
| Q2 2019 | $2,114,000 | +47.0% | 33,426 | +12.0% | 0.01% | +66.7% |
| Q1 2019 | $1,438,000 | +41.4% | 29,850 | -1.7% | 0.00% | 0.0% |
| Q4 2018 | $1,017,000 | -31.3% | 30,367 | +7.5% | 0.00% | 0.0% |
| Q3 2018 | $1,481,000 | +69.5% | 28,259 | +1.2% | 0.00% | +50.0% |
| Q2 2018 | $874,000 | +53.6% | 27,930 | +6.9% | 0.00% | +100.0% |
| Q1 2018 | $569,000 | +5.2% | 26,116 | -2.5% | 0.00% | 0.0% |
| Q4 2017 | $541,000 | +1.7% | 26,791 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $532,000 | +14.9% | 26,791 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $463,000 | +155.8% | 26,791 | +19.7% | 0.00% | – |
| Q1 2017 | $181,000 | +2.8% | 22,386 | 0.0% | 0.00% | – |
| Q4 2016 | $176,000 | -7.9% | 22,386 | 0.0% | 0.00% | – |
| Q3 2016 | $191,000 | -26.8% | 22,386 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $261,000 | – | 22,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |